EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Different Surgical Strategies in Colorectal Cancer Patients With Synchronous Liver Metastasis: A Meta-Analysis

Haitham M Azmy iD, Ali A Shafik, Ahmed Hussein Ahmed, Catherine Emad Saweeres, Osama El Refaie

The American Surgeon™ · 2026-12 · 92 (12) · 3305-3320

DOI: 10.1177/00031348261460472 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The American Surgeon™, online erschienen am 12.06.2026. Verfasst von Haitham M Azmy und 4 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Adenocarcinoma, Colorectal Neoplasms, Hepatectomy, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review aimed to evaluate and compare the short- and long-term outcomes of different treatment strategies for patients with colorectal adenocarcinoma presenting with synchronous liver metastases. A comprehensive literature search was conducted in PubMed (MEDLINE), Cochrane Central Register of Controlled Trials (CENTRAL), Embase, Ovid, and ScienceDirect to identify relevant studies assessing surgical sequencing strategies in patients without extrahepatic disease. Data were extracted and analyzed using Review Manager software. Pooled dichotomous outcomes were expressed as odds ratios (ORs) with 95% confidence intervals (CIs), while continuous outcomes were reported as mean differences (MDs) with corresponding 95% CIs. Three treatment strategies were evaluated: the classical “colon-first” approach, the “liver-first” approach, and the simultaneous resection approach. Overall survival (OS) at 1, 3, and 5 years was the primary outcome. The pooled results demonstrated no statistically significant differences in survival outcomes among the three strategies. When compared with the colon-first approach, simultaneous resection showed comparable 1-year (90.1% vs 87.9%), 3-year (66.5% vs 56.2%), and 5-year survival rates (48% vs 40.7%). Similarly, comparisons between colon-first and liver-first approaches revealed no significant differences in 1-, 3-, or 5-year overall survival. These findings indicate that no single surgical sequencing strategy confers a clear survival advantage. Accordingly, treatment decisions should be individualized, taking into account patient characteristics, hepatic tumor burden, primary tumor features, and institutional expertise within a multidisciplinary framework. Further high-quality randomized controlled trials are needed to better define optimal management strategies for this complex and heterogeneous patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColorectal NeoplasmsHepatectomyLiver NeoplasmsHumansSurvival RateTreatment Outcome

Stichwörter der Autor:innen

colorectal cancerliversimultaneoussurgerysurvival

Autor:innen und Institutionen

  • General Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

ORCID-Profile: Haitham M Azmy

Zitieren

APA

Azmy, H. M., Shafik, A. A., Ahmed, A. H., Saweeres, C. E., & El Refaie, O. (2026). Different Surgical Strategies in Colorectal Cancer Patients With Synchronous Liver Metastasis: A Meta-Analysis. The American Surgeon™, 92(12), 3305-3320. https://doi.org/10.1177/00031348261460472

Vancouver

Azmy HM, Shafik AA, Ahmed AH, Saweeres CE, El Refaie O. Different Surgical Strategies in Colorectal Cancer Patients With Synchronous Liver Metastasis: A Meta-Analysis. The American Surgeon™. 2026;92(12):3305-3320. doi:10.1177/00031348261460472

BibTeX
@article{Azmy2026,
  author = {Azmy, Haitham M and Shafik, Ali A and Ahmed, Ahmed Hussein and Saweeres, Catherine Emad and El Refaie, Osama},
  title = {Different Surgical Strategies in Colorectal Cancer Patients With Synchronous Liver Metastasis: A Meta-Analysis},
  journal = {The American Surgeon™},
  year = {2026},
  volume = {92},
  number = {12},
  pages = {3305--3320},
  doi = {10.1177/00031348261460472}
}
Kostenlos starten →